Surgical Treatment of Talus Osteochondral Lesions with Platelet-Rich Plasma

Full Text

Abstract

Wide application of cell therapy particularly platelet enriched plasma (PRP) in modern orthopaedics enabled to improved treatment results in certain orthopaedic diseases and injury consequences. Treatment results for 7 patients (2 men and 5 women) with osteochondral lesions of talus (OLT) are presented. Mean age of patients was 26 years, mean duration of disease — 4 years. By Brendt and Harty roentgenologic classification I—II degree of OLT was diagnosed in 1 and III—IV degree — in 6 patients. In all patients mosaic chondroplasty of talus with implantation of PRP gel was performed. Postoperatively mean AOFAS index raised from 53 to 92. Follow up period made up around 2 years.

Full Text

Хирургическое лечение остеохондральных поражений таранной кости с использованием плазмы, обогащенной тромбоцитами
×

References

  1. Berndt A.L., Harty M. Transcondylar fractures (osteochondritis dissecans) of the talus. J. Bone Joint Surg. Am. 1959; 41: 988-1020.
  2. Clanton T.O., DeLee J.C. Osteochondritis dissecans. History, pathophysiology, and current treatment concepts. Clin. Orthop. Relat. Res. 1982; 167: 50-64.
  3. Tol J.L., Struijs P.A., Bossuyt P.M., Verhagen R.A., van Dijk C.N. Treatment strategies in osteochondral defects of the talar dome: a systematic review. Foot Ankle Int. 2000; 21 (2): 119-26.
  4. Pettine K.A., Morrey B.F. Osteochondral fractures of the talus. A long-term follow-up. J. Bone Joint Surg. Br. 1987; 69 (1): 89-92.
  5. Zengerink M., Struijs P.A., Tol J.L., van Dijk C.N. Treatment of osteochondral lesions of the talus: a systematic review. Knee Surg. Sports Traumatol. Arthrosc. 2010; 18 (2): 238-46.
  6. Anitua E, Sánchez M., Nurden A.T., Zalduendo M.M., de la Fuente M., Azofra J., Andía I. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford). 2007; 46 (12): 1769-72.
  7. Arnoczky S.P., Anderson L., Fanelli G., Sherwin S.W., Mishra A., Sgaglione N.A. The role of platelet-rich plasma in connective tissue repair. Orthopedics Today. 2009; 26: 29.
  8. Кесян Г.А., Берченко Г.Н., Уразгильдеев Р.З., Микелаишвили Д.С. Сочетанное применение обогащенной тромбоцитами аутоплазмы и биокомпозиционного материала Коллапан в комплексном лечении больных с длительно несрастающимися переломами и ложными суставами длинных костей конечностей. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2011; 2: 26-32.
  9. Микелаишвили Д.С. Применение аутотромбоцитарных факторов роста и коллапана при оперативном лечении диафизарных переломов: Автореф. дис.. канд. мед. наук. М., 2012.
  10. Кесян Г.А., Берченко Г.Н., Уразгильдеев Р.З., Нахапетян Т.Г. Лечение разрывов ахиллова сухожилья. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2011; 4: 80-86.
  11. Dahm D.L., Manzanares J. Osteochondral lesions of the talar dome. Orthopaedic surgery board review manual. Vol. 7, part 2. 2001.

Statistics

Views

Abstract: 115

Cited-by

CrossRef: 1

  1. Silant’Eva TA, Krasnov VV. Effect of Autologous Plasma, Ascorbic Acid and Glucose Local Infusions on Pelvic Fracture Healing in Experiment. Vestnik travmatologii i ortopedii imeni N.N. Priorova. 2014;(1):45. doi: 10.32414/0869-8678-2014-1-45-51

Dimensions

Article Metrics

Metrics Loading ...

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2013 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies